Table 2.
Dose modifications and treatment delays during induction chemotherapy
| TPF (n = 138) | PF (n = 138) | P-Value* | |
|---|---|---|---|
| Dose modifications during induction chemotherapy | |||
| Docetaxel | 60 (43.5) | - | |
| Cisplatin | 7 (5.1) | 21 (15.2) | .005 |
| Fluorouracil | 11 (8.0) | 8 (5.8) | .476 |
| Treatment delays during induction chemotherapy | |||
| Patients who experienced delays, n (%) | 46 (33.3) | 25 (18.1) | .004 |
| Reason for delay | |||
| Hematologic | 26 (18.8) | 13 (9.4) | .025 |
| Non-hematologic | 10 (7.2) | 3 (2.2) | .047 |
| Other† | 10 (7.2) | 9 (6.5) | .812 |
*
Calculated using the χ2 test.
†
Including personal reasons and vacations.